We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRWS:NASDAQCrown Crafts, Inc. Analysis

Data as of 2026-03-27 - not real-time

$2.72

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Crown Crafts trades around $2.72, sitting below its 20‑day, 50‑day and 200‑day moving averages (2.80, 2.90 and 2.87 respectively) and the MACD has turned bearish, indicating short‑term downside pressure despite a modestly increasing volume. The RSI at 42 suggests the stock is not yet oversold, while the current price remains just above the calculated support level of $2.63, leaving limited upside in the near term. Dividend yield appears attractive at nearly 12%, but the payout ratio exceeds 130% and earnings per share are negative, raising serious concerns about sustainability.
From a valuation perspective, the discounted cash‑flow model assigns a fair value of roughly $13.74, implying a substantial discount to market price, and the forward P/E of 3.6 signals a potentially cheap entry point. However, the company’s fundamentals are weak – revenue is down 11%, profit margins are negative, debt totals $26.5 million against a market cap of just $29 million, and ROE is –20%. These factors, combined with a volatile 30‑day price swing of over 27% and a low‑beta (≈0.6) exposure to market moves, paint a picture of a high‑risk, value‑oriented play in the consumer cyclical sector.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD histogram
  • Unsustainable dividend payout

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant discount to DCF fair value
  • Potential for earnings turnaround
  • High debt load limiting flexibility

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Deep valuation gap versus intrinsic value
  • Structural challenges in profitability
  • Consumer cyclical exposure to economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth-11.30%
Profit Margin-11.10%
P/E Ratio3.6
ROE-20.43%
ROA1.45%
Debt/Equity67.62
P/B Ratio0.7
Op. Cash Flow$9.9M
Free Cash Flow$12.7M

Technical Analysis

TrendNeutral
RSI42.0
Support$2.63
Resistance$3.04
MA 20$2.80
MA 50$2.90
MA 200$2.87
MACDBearish
VolumeIncreasing
Fear & Greed Index72.43

Valuation

Fair Value$13.74
GradeUndervalued
TypeValue
Dividend Yield11.94%

Risk Assessment

Beta0.62
Volatility27.31%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.